TY - JOUR AU - Skvarc, David R. AU - Dean, Olivia M. AU - Byrne, Linda K. AU - Gray, Laura J. AU - Ives, Kathryn AU - Lane, Stephen E. AU - Lewis, Matthew AU - Osborne, Cameron AU - Page, Richard AU - Stupart, Douglas AU - Turner, Alyna AU - Berk, Michael AU - Marriott, Andrew J. PY - 2016 DA - 2016/08/09 TI - The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial JO - Trials SP - 395 VL - 17 IS - 1 AB - Some degree of cognitive decline after surgery occurs in as many as one quarter of elderly surgical patients, and this decline is associated with increased morbidity and mortality. Cognition may be affected across a range of domains, including memory, psychomotor skills, and executive function. Whilst the exact mechanisms of cognitive change after surgery are not precisely known, oxidative stress and subsequent neuroinflammation have been implicated. N-acetylcysteine (NAC) acts via multiple interrelated mechanisms to influence oxidative homeostasis, neuronal transmission, and inflammation. NAC has been shown to reduce oxidative stress and inflammation in both human and animal models. There is clinical evidence to suggest that NAC may be beneficial in preventing the cognitive decline associated with both acute physiological insults and dementia-related disorders. To date, no trials have examined perioperative NAC as a potential moderator of postoperative cognitive changes in the noncardiac surgery setting. SN - 1745-6215 UR - https://doi.org/10.1186/s13063-016-1529-4 DO - 10.1186/s13063-016-1529-4 ID - Skvarc2016 ER -